AJMC July 17, 2024
Laura Joszt, MA

While the risk of developing long COVID after a SARS-CoV-2 infection remains a persistent threat, it decreased significantly over the course of the COVID-19 pandemic. The decline is largely attributed to vaccination against COVID-19, according to a new study published in New England Journal of Medicine (NEJM).1

Ziyad Al-Aly, MD, a clinical epidemiologist with Washington University School of Medicine in St. Louis and a nephrologist at John J. Cochran Veterans Hospital in St. Louis, said the declining rates of long COVID is a rare occasion of good news regarding COVID-19.2 However, he emphasized that long COVID remains a challenge.

Presentation and Prevalence of Long COVID

Long COVID, or postacute sequelae of SARS-CoV-2 (PASC), affects many organ systems, and the risk...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Trends
Understanding the Growing Impact of Obesity in the United States
Wearable electrical nerve stimulation device eases long COVID pain and fatigue, say researchers
Transforming public health: a physician’s innovative approach [PODCAST]
Trump Nominates Physicians for CDC Director, Surgeon General
5 Things You Should Know About Long COVID

Share This Article